FOXP3 and cervical carcinoma: In cervical cancer, artesunate inhibits in situ tumor growth and exerts antitumor effects by suppressing PGE2 production in CaSki and HeLa cells and downregulating Foxp3 expression in T cells (Zhang et al., 2014).